The importance of rehabilitation with cardiovascular diabetic patients after surgical interventions;Die bedeutung der rehabilitation beim herzkranken diabetiker nach chirurgischen eingriffen

Clinical Research in Cardiology

Volumn 95, Issue 1 SUPPL., 2006, Pages

  Jacob, S ^a  

^a Forum für Vaskuläre Medizin eV ^*  (Germany)

Author keywords

Cardiovascular disease; Diabetes mellitus; Metabolic control; Rehabilitation

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; HEART REHABILITATION; HUMAN; PROGNOSIS; REVIEW; RISK ASSESSMENT; STANDARDIZATION;

BLOOD GLUCOSE; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INTERDISCIPLINARY COMMUNICATION; LIFE STYLE; PROGNOSIS; RISK FACTORS;

EID: 31544452077     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-006-1108-x     Document Type: Review

References (26)

1. Becker A, Bos G, de Vegt F, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD (2003) Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn Study. Eur Heart J 24(15):1406-1413
2. Church TS, Cheng YJ, Earnest CP, Barlow CE, Gibbons LW, Priest EL, Blair SN (2004) Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes Care 27(1):83-88
3. Dalal H, Evans PH, Campbell JL (2004) Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction BMJ 328:693-697
4. DECODE Study Group. Glucose tolerance and cardiovascular mortality: comparison of the fasting and the 2-hour diagnostic criteria. Arch Intern Med 161:397-404
5. de Lorgeril M, Salen P, Martin JL et al (1999) Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99:779-785
6. Dendale P, Berger J, Hansen D, Vaes J, Benit E, Weymans M (2005) Cardiac rehabilitation reduces the rate of major adverse cardiac events after percutaneous coronary intervention. Eur J Cardiovasc Nurs 4(2):113-116
7. Gæde P, Vedel N, Larsen GVH, Jensen HH, Parving OP (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. New Engl Journal Med Volume 348:383-393
8. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234
9. Hambrecht R, Walther C, Mobius-Winkler S, Gielen S, Linke A, Conradi K, Erbs S, Kluge R, Kendziorra K, Sabri O, Sick P, Schuler G (2004) Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation. 109:1371-1378
10. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24(4):683-689
11. Jacob S, Keulen L, Jacob F, Balletshofer B, Häring HU, Lang R (2004) Typ 2 Diabetes, Störungen des Glukose-Stoffwechsels und vaskuläre Erkrankungen. Journal für Kardiologie 11:392-395
12. Jacob S, Scherer SJ, Klimm HD, Renn W, Keulen L, Scharnagl H, Schlageter S, Keller H, Weismann G, Austin HJ, März W, Häring HU (2004) Insulin resistance and disorders of glucose metabolism in survivors of myocardial infarction. Perfusion 17:228-234
13. Jacob S, Motz W, Steinhagen-Thiessen E, Tschöpe D (2003) Minimal metabolic data set for patients at high vascular risk. Exp Clin Endocrinol Diabetes 111:471-474
14. Jacob S (2005) Antihyperglykämika. In: Meinertz T, Rosen P, Schömig A, Tschöpe D, Ziegler D (Hrsg) Diabetes und Herz, 1. Aufl. Steinkopff, Darmstadt, S 354-362
15. Kuusisto J, Lempiäinen P, Mykkänen L, Laakso M (2001) Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men. Diabetes Care 24:1629-1633
16. Kowalska I, Prokop J, Bachorzewska-Gajewska H, Telejko B, Kinalskal I, Kochmn W, Musial W (2001) Disturbances of glucose metabolism in men referred for coronary arteriography. Postload glycemia as predictor for coronary artherosclerosis. Diabeste Care 24:897-901
17. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS (2004) Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109:1497-1502
18. Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenström A for the DIGAMI 2 Investigators (2005) Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. European Heart Journal 26:650-661
19. Meigs JB, Nathan DM, D'Agostino RB, Wilson PWF (2002) Fasting and postchallenge glycemia and cardiovascular disease risk. The Framingham Offspring Study Diabetes Care 25:1845-1850
20. Murchie P, Campbell NC, Ritchie LD, Simpson JA, Thain J (2003) Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care. BMJ (326)84:1-6
21. Norhammer A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K (2002) Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140-2144
22. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL, Hogeboom C, Brand RJ (1998) Intensive lifestyle changes for reversal of coronary heart disease. JAMA 280:2001-2007
23. Qiao Q, Tuomilehto J, Borch-Johnsen K (2003) Post-challenge hyperglycaemia is associated with premature death and macrovascular complications. Diabetologia 46(Suppl 1):M17-21
24. Schnell O, Schafer O, Kleybrink S, Doering W, Standl E, Otter W (2004) Munich registry: intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: the Munich registry. Diabetes Care 27:455-460
25. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321(7258):405-412
26. Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefebvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Koranyi L, Laakso M, Mokan M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J (2005) PROactive investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): a randomised controlled trial. Lancet 366(9493): 1279-1289